Daily Bulletin

Men's Weekly

.

Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic Leukaemia (APL) Confirm Bioequivalence of Oral and IV Formulations

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Cision

SYDNEY, May 14, 2021 /PRNewswire/ -- Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference.

The abstract builds on the initial bioequivalence data from the first phase of the...

Read more: Final Results of Bioavailability Study of Phebra's Oral Arsenic Capsule for Acute Promyelocytic...

Business News

Car Rental as a Practical and Flexible Solution for Travel or Work

The contemporary, hectic way of life is one of ease and adaptability while commuting and working. Regardless of whether one moves around by road, commuting between towns for conferences, or taking a f...

Daily Bulletin - avatar Daily Bulletin

Car Park Markings Melbourne: How Quality Line Marking Shapes Safer Spaces

In modern busy urbanized societies, structured parking areas are necessary in terms of both security and convenience. At a shopping center, business establishment, or a publicly-accessible facility, t...

Daily Bulletin - avatar Daily Bulletin

Cleaning Australia: The Rise of Professional Cleaning Services

The cleaning industry in Australia is booming as more people are opting for professional cleaning services to keep their homes, offices, and businesses spotless. With the increasing demand for cleanli...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business